Patents by Inventor Brendan John Fallon

Brendan John Fallon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Naphthyridine derivatives useful as alpha-V-beta-6 integrin antagonists
    Patent number: 10450312
    Abstract: A compound of formula (I) or a salt thereof wherein R1 represents a hydrogen atom, a methyl group or a ethyl group R2 represents a hydrogen atom or a fluorine atom R3 represents a hydrogen atom, a methyl group or an ethyl group.
    Type: Grant
    Filed: June 13, 2018
    Date of Patent: October 22, 2019
    Assignee: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: Niall Andrew Anderson, Brendan John Fallon, John Martin Pritchard
  • NAPHTHYRIDINE DERIVATIVES USEFUL AS ALPHA-V-BETA-6 INTEGRIN ANTAGONISTS
    Publication number: 20180291022
    Abstract: A compound of formula (I) or a salt thereof wherein R1 represents a hydrogen atom, a methyl group or a ethyl group R2 represents a hydrogen atom or a fluorine atom R3 represents a hydrogen atom, a methyl group or an ethyl group.
    Type: Application
    Filed: June 13, 2018
    Publication date: October 11, 2018
    Inventors: Niall Andrew ANDERSON, Brendan John FALLON, John Martin PRITCHARD
  • Naphthyridine derivatives useful as ??integrin antagonists
    Patent number: 10023568
    Abstract: A compound of formula (I) or a salt thereof wherein R1 represents a hydrogen atom, a methyl group or a ethyl group R2 represents a hydrogen atom or a fluorine atom R3 represents a hydrogen atom, a methyl group or an ethyl group.
    Type: Grant
    Filed: March 26, 2014
    Date of Patent: July 17, 2018
    Assignee: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: Niall Andrew Anderson, Brendan John Fallon, John Martin Pritchard
  • NAPHTHYRIDINE DERIVATIVES USEFUL AS ALPHA-V-BETA-6 INTEGRIN ANTAGONISTS
    Publication number: 20160280705
    Abstract: A compound of formula (I) or a salt thereof wherein R1 represents a hydrogen atom, a methyl group or a ethyl group R2 represents a hydrogen atom or a fluorine atom R3 represents a hydrogen atom, a methyl group or an ethyl group.
    Type: Application
    Filed: March 26, 2014
    Publication date: September 29, 2016
    Inventors: Niall Andrew Anderson, Brendan John Fallon, John Martin Pritchard